Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

News > All

Total search results: 16840 | Ordered by Date (descending)
1 2 3 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Berlin Partner. (April 2019). "Special Feature: BIONNALE 2019 in Berlin – the Networking Event for the Life Sciences & Healthcare Industries in the German Capital Region". Berlin. 2019-04-18
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. 2019-04-17
Lipotype GmbH. (4/16/19). "Press Release: Worldwide First and Only Shotgun Lipidomics Service Provider with Official GMP Certificate". Dresden. 2019-04-16
Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne. 2019-04-16
Inivata Ltd.. (4/16/19). "Press Release: Inivata, Thermo Fisher Scientific, and Genomics England Successfully Complete First Phase of Study Assessing Plasma Samples and Potential of Liquid Biopsy". 2019-04-16
MLM Medical Labs GmbH. (4/15/19). "Press Release: Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project to Enable Development and Implementation of Novel Safety Biomarkers". Mönchengladbach. 2019-04-15
Immunic, Inc.. (4/12/19). "Press Release: Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases". San Diego, CA & Martinsried. 2019-04-12
Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd. 2019-04-12
Sophia Genetics S.A.. (4/11/19). "Press Release: Sophia Genetics Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection". Lausanne. 2019-04-11
Evotec SE. (4/11/19). "Press Release: Evotec and Indivumed Announce Strategic Drug Discovery Collaboration on Precision Medicine for Colorectal Cancer". Hamburg. 2019-04-11
Centogene AG. (4/10/19). "Press Release: Centogene Launches CentoMetabolic Panel for Integrated Multiomic Testing for Metabolic Diseases". Rostock & Berlin. 2019-04-10
Synaffix B.V.. (4/10/19). "Press Release: Synaffix Announces $125m License Agreement with Shanghai Miracogen". Amsterdam. 2019-04-10
Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). 2019-04-09
Theranexus S.A.. (4/9/19). "Press Release: Theranexus Announces Research Collaboration with IRISA Using Artificial Intelligence Technologies to Enhance Therapeutic Targeting of Neurological Interactions". Lyon. 2019-04-09
Kymab Ltd.. (4/8/19). "Press Release: Kymab Appoints Simon Sturge as Chief Executive Officer". Cambridge. 2019-04-08
Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge. 2019-04-08
Uniqure N.V.. (4/8/19). "Press Release: Uniqure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntington’s Disease". Lexington, MA & Amsterdam. 2019-04-08
Eppendorf AG. (4/5/19). "Press Release: Eppendorf AG Increases Sales and Earnings in 2018 and Accelerates Organic Growth". Hamburg. 2019-04-05
Phenex Pharmaceuticals AG. (4/5/19). "Press Release: Phenex Collaborates with Mathias Heikenwälder’s Research Group from DKFZ (German Cancer Research Center)". Ludwigshafen. 2019-04-05
Crescendo Biologics Ltd.. (4/4/19). "Press Release: Theodora Harold to Be Appointed New CEO at Crescendo Biologics". Cambridge. 2019-04-04
Probiodrug AG. (4/4/19). "Press Release: Probiodrug AG has Mandated Oddo Seydler Bank AG as Designated Sponsor. The Shares Are Trading on XETRA, the Electronic Trading Platform of Deutsche Börse". Halle (Saale). 2019-04-04
Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA. 2019-04-04
Novartis AG. (4/4/19). "Press Release: Novartis Updates on the Migraine Collaboration with Amgen". Basel. 2019-04-04
Medigene AG. (4/4/19). "Press Release: Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia". Martinsried & Hong Kong. 2019-04-04
Gesynta Pharma AB. (4/4/19). "Press Release: Gesynta Pharma Secures 6 MEUR for Development Programs in Financing Round Led by Industrifonden". Solna. 2019-04-04
Dyne Therapeutics. (4/3/19). "Press Release: Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases". Cambridge, MA. 2019-04-03
Roche. (4/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Withdrawal and Refiling of Premerger Notification and Report Form under the HSR Act and Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. 2019-04-03
AgomAb Therapeutics N.V.. (4/3/19). "Press Release: AgomAb Therapeutics Completes Euros 21m Series A Financing". Ghent. 2019-04-03
Novartis AG. (4/3/19). "Press Release: Sandoz Resubmits Biosimilar Pegfilgrastim Application to US FDA". Holzkirchen. 2019-04-03
Qiagen N.V.. (4/3/19). "Press Release: Qiagen and LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals". Hilden & Germantown, MD. 2019-04-03
ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. 2019-04-03
Bruker Corporation. (4/3/19). "Press Release: Bruker Announces Acquisition of Rave LLC". Billerica, MA. 2019-04-03
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Announces Agreement Securing Access To Large-scale, Commercial-grade Manufacturing Capacity at Brammer Bio". Brisbane, CA. 2019-04-02
Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel. 2019-04-02
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy". Brisbane, CA & New York, NY. 2019-04-02
Centogene AG. (4/2/19). "Press Release: Centogene Announces the Appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman". Rostock & Berlin. 2019-04-02
Nanobiotix S.A.. (4/2/19). "Press Release: Combination of First-in-Class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in Vivo Models of Lung Cancer". Paris & Cambridge, MA. 2019-04-02
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data". Brisbane, CA. 2019-04-02
Novartis AG. (4/2/19). "Press Release: Novartis First-in-class Cosentyx Approved in China for Psoriasis Patients". Basel. 2019-04-02
Bayer AG. (4/2/19). "Press Release: Leaps by Bayer and Khloris Join Forces to Develop Induced Pluripotent Stem Cells (iPSCs) as Breakthrough Anti-cancer Vaccines". Leverkusen & South San Francisco, CA. 2019-04-02
Karuna Therapeutics, Inc.. (4/1/19). "Press Release: Karuna Completes $80 Million Series B Financing". Boston, MA. 2019-04-01
Metrion Biosciences Ltd.. (4/1/19). "Press Release: Metrion Biosciences Closes Funding Round. Includes investment from o2h Ventures Therapeutics Fund". Cambridge. 2019-04-01
Surface Oncology Inc.. (4/1/19). "Press Release: Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer". Cambridge, MA. 2019-04-01
Roche. (4/1/19). "Press Release: Roche’s Ipatasertib in Combination with Tecentriq and Chemotherapy Shows Promising Anti-tumour Activity in Triple-negative Breast Cancer in Early Phase Trial". Basel. 2019-04-01
Cell Mogrify Ltd.. (4/1/19). "Press Release: Mogrify Subsidiary Chondrogenix Secures Funding from SBRI Healthcare to Advance Regenerative Cartilage Therapy to the Clinic". Cambridge. 2019-04-01
Novartis AG. (4/1/19). "Press Release: Novartis Adds Clinical and Preclinical Anti-inflammatory Programs to Portfolio with Acquisition of IFM Tre". Basel. 2019-04-01
Novartis AG. (4/1/19). "Press Release: AveXis Expands World-leading Gene Therapy Manufacturing Capacity with Purchase of Advanced Biologics Therapy Manufacturing Campus in Longmont, Colorado". Basel. 2019-04-01
Mologic Ltd.. (4/1/19). "Press Release: Mologic Expands US and UK Operations. Strengthens Team as Part of Continued International Expansion – Bolsters US Presence with the Opening of Subsidiary in Boston, MA". Bedfordshire. 2019-04-01
MorphoSys AG. (4/1/19). "Press Release: Dr. Sarah Fakih Joins MorphoSys as Head of Corporate Communications and Investor Relations". Planegg. 2019-04-01
Cambridge Innovation Capital plc. (4/1/19). "Press Release: Cambridge Innovation Capital Completes £150 Million New Capital Raise". 2019-04-01
Bluebird Bio, Inc.. (3/29/19). "Press Release: Bluebird Bio Receives Positive Opinion from CHMP for Zynteglo (autologous CD34+ cells encoding ßA-T87Q-globin gene) Gene Therapy". Cambridge, MA. 2019-03-29
Indivumed GmbH. (3/28/19). "Press Release: Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services". Hamburg & Westminster, CO. 2019-03-28
Selvita S.A.. (3/28/19). "Press Release: Selvita to Separate Oncology Therapeutics and Contract Research Business Units into Two Global Companies". Krakow. 2019-03-28
Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge. 2019-03-28
Qiagen N.V.. (3/28/19). "Press Release: Qiagen Launches Novel Liquid Biopsy Solutions and NGS Panels with Seamlessly Integrated Bioinformatics to Support Advances in Cancer Research". Germantown, MD & Hilden. 2019-03-28
Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris. 2019-03-28
Probiodrug AG. (3/28/19). "Press Release: Probiodrug Reports Full Year 2018 Financial Results". Halle (Saale). 2019-03-28
ProteoNic Biotechnology B.V.. (3/28/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Bayer". Leiden. 2019-03-28
Selvita S.A.. (3/28/19). "Press Release: Selvita Posts 67 Percent Increase in Operating Profit for Services Division, Innovative Research Division Reaches Inflection Point as SEL120 Enters Clinical Development". Krakow. 2019-03-28
Celyad S.A.. (3/28/19). "Press Release: Celyad Reports Business Update and Full Year 2018 Financial and Operating Results". Mont-Saint-Guibert. 2019-03-28
ArcherDX, Inc.. (3/28/19). "Press Release: ArcherDX Announces Collaboration with University College London to Investigate the Novel Use of Cell-Free Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients". Boulder, CO. 2019-03-28
Celyad S.A.. (3/28/19). "Press Release: Celyad Appoints Filippo Petti as Chief Executive Officer. Dr Christian Homsy Continues as Non-executive Director and Chair of the Strategy Committee of the Board of Directors". Mont-Saint-Guibert. 2019-03-28
Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel. 2019-03-28
Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. 2019-03-27
Genfit S.A.. (3/27/19). "Press Release: Genfit Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market". Lille & Cambridge, MA. 2019-03-27
Cerenis Therapeutics S.A.. (3/27/19). "Press Release: Cerenis Therapeutics and H4Orphan Pharma Enter into Exclusive Negotiations to Consider a Strategic Merger". Toulouse. 2019-03-27
Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin. 2019-03-27
Evaluate Ltd.. (3/26/19). "Press Release: Evaluate Ltd. Appoints Deborah Kobewka as Chief Executive Officer". London, Boston, MA & Tokyo. 2019-03-26
Curetis N.V.. (3/26/19). "Press Release: Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero". Amsterdam & Holzgerlingen. 2019-03-26
Enamine Ltd.. (3/26/19). "Press Release: Enamine Extends Multi-year Drug Discovery Collaboration with Lundbeck". Kiev. 2019-03-26
Evotec AG. (3/26/19). "Press Release: Evotec and The Mark Foundation for Cancer Research Announce Strategic Collaboration in Immuno-oncology". Hamburg. 2019-03-26
Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH". 2019-03-26
MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY. 2019-03-26
Synerkine Pharma B.V.. (3/25/19). "Press Release: Synerkine Pharma Raises EUR3.3 Million in Series A Financing". Utrecht. 2019-03-25
PharmaMar S.A.. (3/25/19). "Press Release: PharmaMar Announces Positive Results in Its Lurbinectedin Monotherapy Trial for Small Cell Lung Cancer". Madrid. 2019-03-25
Aimmune Therapeutics, Inc.. (3/25/19). "Press Release: European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint. Company Intends to Submit European MAA in Mid-2019". Brisbane, CA. 2019-03-25
Thermo Fisher Scientific Inc.. (3/24/19). "Press Release: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing". Waltham, MA & Cambridge, MA. 2019-03-24
Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London. 2019-03-21
Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London. 2019-03-21
Cambridge Cancer Genomics Ltd.. (3/21/19). "Press Release: Genomics England and Cambridge Cancer Genomics (CCG.ai) Announce Immunotherapy Partnership". Cambridge. 2019-03-21
Pierre Fabre S.A.. (3/21/19). "Press Release: Institut Curie and Pierre Fabre Strengthen Their Immuno-oncology Partnership". Paris & Castres. 2019-03-21
NeoPhore Ltd.. (3/20/19). "Press Release: NeoPhore Appoints Dr John Haurum as Non-Executive Director. Former F-star CEO Joins the Board of Directors". 2019-03-20
Atlatl Innovation Cluster. (3/20/19). "Press Release: Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai". Shanghai. 2019-03-20
4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. 2019-03-20
Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY. 2019-03-20
Roche. (3/19/19). "Press Release: FDA Approves Roche’s Tecentriq in Combination with Chemotherapy for the Initial Treatment of Adults with Extensive-stage Small Cell Lung Cancer". Basel. 2019-03-19
Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. 2019-03-19
Affimed N.V.. (3/19/19). "Press Release: Affimed Announces Milestone Payment from Genentech and ROCK Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity". Heidelberg. 2019-03-19
Karuna Therapeutics, Inc.. (3/18/19). "Press Release: Karuna Announces $68 Million Series B Financing". Boston, MA. 2019-03-18
Orchard Therapeutics Ltd.. (3/18/19). "Press Release: Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer". Boston, MA & London. 2019-03-18
Cell Mogrify Ltd.. (3/18/19). "Press Release: Mogrify Awarded $555,000 USD (£420,000 GBP) Innovate UK Funding to Accelerate Regenerative Cell Therapies". Cambridge. 2019-03-18
Mologen AG. (3/18/19). "Press Release: Early Departure of CEO". Berlin. 2019-03-18
SilverSky LifeSciences GmbH. (3/18/19). "Press Release: DxPx – The First International Diagnostics Partnering Conference". Düsseldorf. 2019-03-18
Celyad S.A.. (3/18/19). "Press Release: Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates". Mont-Saint-Guibert. 2019-03-18
Merck KGaA. (3/14/19). "Press Release: Merck Announces Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-03-14
Genfit S.A.. (3/14/19). "Press Release: Genfit Announces Launch of Proposed Global Offering and Nasdaq Listing". Lille & Cambridge, MA. 2019-03-14
Bruker Corporation. (3/14/19). "Press Release: Bruker Announces Acquisition of Scientific Software Provider Arxspan". Billerica, MA. 2019-03-14
CARB-X. (3/14/19). "Press Release: Germany Joins CARB-X Partnership in the Fight against Deadly Drug-resistant Superbugs". Berlin. 2019-03-14
Cambrex Corporation. (3/14/19). "Press Release: Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan". East Rutherford, NJ. 2019-03-14
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
1 2 3 ... 167 168 169  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

» top